251 related articles for article (PubMed ID: 4947068)
1. [Antihypertensive therapy and prognosis: hemodynamic aspect].
Ogino K
Saishin Igaku; 1971 Dec; 26(12):2314-23. PubMed ID: 4947068
[No Abstract] [Full Text] [Related]
2. Hemodynamic measurements as aids to choosing drug treatment of essential hypertension.
Chen HC
Clin Ther; 1985; 7(2):176-80. PubMed ID: 3986862
[TBL] [Abstract][Full Text] [Related]
3. [Results of long-term therapy of arterial hypertension].
Reubi F
Schweiz Med Wochenschr; 1973 Nov; 103(47):1690-2. PubMed ID: 4594047
[No Abstract] [Full Text] [Related]
4. [Behavior of hemodynamic values of patients with hypertension during dichlorphenylamino-imidazoline therapy].
Pozenel H
Wien Klin Wochenschr; 1969 Mar; 81(11):187-92. PubMed ID: 4935483
[No Abstract] [Full Text] [Related]
5. Essential malignant hypertension. Clinicopathologic correlations.
Susin M; Mailloux LU
N Y State J Med; 1978 Jan; 78(1):54-8. PubMed ID: 272499
[No Abstract] [Full Text] [Related]
6. Hemodynamic effects of antihypertensive drugs.
Itskovitz HD
Am Fam Physician; 1983 Jun; 27(6):137-42. PubMed ID: 6134461
[TBL] [Abstract][Full Text] [Related]
7. [Benefits and risks of hypertension therapy from the cardiac viewpoint].
Motz W; Strauer BE
Z Kardiol; 1994 Mar; 83(3):179-87. PubMed ID: 8178541
[TBL] [Abstract][Full Text] [Related]
8. [Heart, brain and hypertension].
Lüscher TF; Sturzenegger M; Noll G
Schweiz Med Wochenschr; 1996 Aug; 126(34):1449-56. PubMed ID: 8848709
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) at rest and during exercise with special respect to the pulmonary circulation.
Koch G
Arzneimittelforschung; 1971 Jan; 21(1):57-61. PubMed ID: 5108382
[No Abstract] [Full Text] [Related]
10. Malignant hypertension. A clinical follow-up study with special reference to renal and cardiovascular function and immunogenetic factors.
Gudbrandsson T
Acta Med Scand Suppl; 1981; 650():1-62. PubMed ID: 6948498
[No Abstract] [Full Text] [Related]
11. [Medically treated severe arterial hypertension. Long term course].
Safar M; Simon A; Maiz B; Weiss Y; Milliez P
Nouv Presse Med; 1975 May; 4(19):1403-6. PubMed ID: 807910
[TBL] [Abstract][Full Text] [Related]
12. [Changes in cerebral and central hemodynamics in response to hypotensive therapy of patients with essential hypertension and different types of circulation].
Sidorenko GI; Pavolova AI; Gaĭduk VN; Al'khimovich VM; Nechesova TA
Ter Arkh; 1986; 58(11):18-21. PubMed ID: 2881362
[TBL] [Abstract][Full Text] [Related]
13. [Clinical aspects and therapy of the hypertensive emergency].
Stumpe KO
Internist (Berl); 1984 Jun; 25(6):359-66. PubMed ID: 6384105
[No Abstract] [Full Text] [Related]
14. Retrospective and prospective research on hypertension-related end-organ damage.
Perloff D
J Cardiovasc Pharmacol; 1994; 24 Suppl A():S1-5. PubMed ID: 7603071
[TBL] [Abstract][Full Text] [Related]
15. Serial hemodynamic measurements allow better blood pressure control than clinical judgment in those with refractory hypertension.
Basile J
J Clin Hypertens (Greenwich); 2002; 4(6):434-5. PubMed ID: 12461310
[No Abstract] [Full Text] [Related]
16. [Circadian rhythms of hemodynamic load on the cardiovascular system in patients with essential hypertension: implication for drug therapy rationale].
Komarov FI; Ol'binskaia LI; Khapaev VA
Klin Med (Mosk); 2001; 79(3):52-5. PubMed ID: 11490420
[TBL] [Abstract][Full Text] [Related]
17. [Labile arterial hypertension, Hemodynamic forms].
Tourniaire A; Blum J; Tartulier M; Lestaevel M
Arch Mal Coeur Vaiss; 1972 Oct; 65(10):1179-94. PubMed ID: 4632663
[No Abstract] [Full Text] [Related]
18. Hypertension in the elderly.
Kirkendall WM; Hammond JJ
Arch Intern Med; 1980 Sep; 140(9):1155-61. PubMed ID: 7406612
[TBL] [Abstract][Full Text] [Related]
19. [Heart of the hypertonic patient. Prognosis, therapeutic guidelines, appraisal].
Anschütz F
Fortschr Med; 1973 Jan; 91(1):8-11. PubMed ID: 4699342
[No Abstract] [Full Text] [Related]
20. [New goals in hypertension management: target-organ protection beyond blood pressure lowering].
Safar ME; Struijker-Boudier HA
Drugs; 2003; 63 Spec No 1():45-7. PubMed ID: 12708882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
